Note:


we have news on one of our patents... YYYIIIIIIIIIIPEEEEEEEEEEEEE

7 SURVIVIN in my patents list
Inventor: HAYES IAN (IE); COTTER TOM (IE); (+5) Applicant: EIRX THERAPEUTICS LTD (IE); HAYES IAN (IE); (+6)
EC: C07K14/47A1A; C07K14/47A33 IPC: C07K14/47; A61K38/00; C07K14/435 (+2)
Publication info: WO03091384 - 2003-11-06


read the link

Lilly Highlights Two Collaboration Drugs in Its Pipeline Update
PR Newswire (press release), NY - 22 hours ago
- Plans Broad Phase 2 Cancer Trials for Survivin ASO to Begin Late in 2006 and 2007 - CARLSBAD, Calif., Dec. 11 /PRNewswire-FirstCall ...

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-11-2006/0004488564&EDATE=


Look at patent list for Eirx re: SURVIVIN patent number 7

http://v3.espacenet.com/results?sf=a&FIRST=1&CY=gb&LG=en&DB=EPODOC&TI=&AB=&PN=&AP=&PR=&PD=&PA=eirx&IN=&EC=&IC=&=&=&=&=&=

MGI Pharam webcast tonight.. so should get an update on how ZYC300 is progressing

On the subject of finance, EiRx will be at the Ireland-Europe BioPartnering 2007 conference on 21 November 2007, see the following link for company profiles and agenda:

http://www.biotechnologyireland.com/pooled/articles/BF_EVENTART/view.asp?Q=BF_EVENTART_293930

They clearly intend to be in business then, so this bust next week talk, I'm afraid is incorrect.

By the way, if anyone is in Dublin on that day, you can sign up to meet EiRx and hear them talk.

.